The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

Rmosek: The R to MOSEK Optimization Interface

This is a meta-package designed to support the installation of Rmosek (>= 6.0) and bring the optimization facilities of MOSEK (>= 6.0) to the R-language. The interface supports large-scale optimization of many kinds: Mixed-integer and continuous linear, second-order cone, exponential cone and power cone optimization, as well as continuous semidefinite optimization. Rmosek and the R-language are open-source projects. MOSEK is a proprietary product, but unrestricted trial and academic licenses are available.

Version: 1.3.5
Suggests: pkgbuild
Published: 2019-08-01
DOI: 10.32614/CRAN.package.Rmosek
Author: MOSEK ApS
Maintainer: Henrik A. Friberg <haf at mosek.com>
Contact: MOSEK ApS <rmosek@mosek.com>
License: LGPL-2.1 | LGPL-3 [expanded from: LGPL (≥ 2.1)]
URL: http://www.mosek.com/
NeedsCompilation: no
SystemRequirements: MOSEK (>= 6) and MOSEK License (>= 6)
Materials: NEWS
In views: Optimization
CRAN checks: Rmosek results

Documentation:

Reference manual: Rmosek.pdf

Downloads:

Package source: Rmosek_1.3.5.tar.gz
Windows binaries: r-devel: Rmosek_1.3.5.zip, r-release: Rmosek_1.3.5.zip, r-oldrel: Rmosek_1.3.5.zip
macOS binaries: r-release (arm64): Rmosek_1.3.5.tgz, r-oldrel (arm64): Rmosek_1.3.5.tgz, r-release (x86_64): Rmosek_1.3.5.tgz, r-oldrel (x86_64): Rmosek_1.3.5.tgz
Old sources: Rmosek archive

Reverse dependencies:

Reverse depends: freebird
Reverse imports: cmaRs, dipw, lincom, RCBR
Reverse suggests: ivmte, klic, mdw, REBayes
Reverse enhances: CVXR, designmatch, DoE.MIParray, sbw

Linking:

Please use the canonical form https://CRAN.R-project.org/package=Rmosek to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.